carbamates has been researched along with Lymphoma, T-Cell in 1 studies
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Fractionation of the crude extract led to the isolation of a new cytotoxin, designated santacruzamate A (1), which has several structural features in common with suberoylanilide hydroxamic acid [(2), SAHA, trade name Vorinostat], a clinically approved histone deacetylase (HDAC) inhibitor used to treat refractory cutaneous T-cell lymphoma." | 3.79 | Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp. ( Balunas, MJ; Engene, N; Gerwick, WH; Lopez, DD; McPhail, KL; Ononye, S; Pavlik, CM; Wong, CY, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavlik, CM | 1 |
| Wong, CY | 1 |
| Ononye, S | 1 |
| Lopez, DD | 1 |
| Engene, N | 1 |
| McPhail, KL | 1 |
| Gerwick, WH | 1 |
| Balunas, MJ | 1 |
1 other study available for carbamates and Lymphoma, T-Cell
| Article | Year |
|---|---|
Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp.
Topics: Carbamates; Cyanobacteria; Cytotoxins; Drug Screening Assays, Antitumor; HCT116 Cells; Histone Deace | 2013 |